SEC Tracker
Get the app
VJET · XBRL financial data

Catheter Precision financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (VJET's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024†Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025†Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue133128*829396———————
Revenue from contracts with customers—year only829396149*143212226238*4321,019
Cost of revenue67*51610———————
Cost of goods and services sold—year only5161011*11141820*42921
Gross profit127121*777786138*132198208218*39098
Research and development112(11)*37816391*——————
Selling, general and administrative2,7452,729*2,6562,7132,8823,098*3,4852,8812,9532,756*2,5593,911
Total operating expenses2,8572,718*2,6932,7942,9453,189*3,7074,8843,22910,079*2,7084,053
Other operating income (expense)803—(59)(1,503)(1,261)———————
Operating income (loss)(2,730)(2,597)*(2,616)(2,717)(2,859)(3,051)*(3,575)(4,686)(3,021)(9,861)*(2,318)(3,955)
Interest income—year only337734*183103*24
Interest expense0———32———————
Other income (expense)803(5,627)*(3)(1)(3)(3)*0(1)(5)4*(5)(54)
Income tax expense (benefit)00*0003,141*(724)(950)78(214)*(175)(312)
Net income (loss)(1,927)(669)*(2,675)(4,220)(4,120)(5,628)*(4,045)(5,109)(2,251)(5,778)*(1,681)(3,295)
Earnings per share, basic USD per share——(3.60)(5.57)(38.17)—(0.36)(0.38)(1.70)—(1.39)(0.92)
Weighted average shares, basic thousands of shares——743757108—11,28413,3361,321—2,1922,767
  • † Share count changed about 8x in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/14 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (VJET's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024†Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025†Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents5,5793,5651,491161,2682,8734508381,07588441643
Marketable securities—————————0—1,196
Accounts receivable46137731051077085115123155261120
Inventory644463633233714834866288
Prepaid and other current assets8741532720430731624817125461485463
Total current assets5,7764,1611,9543881,7143,2928542,0462,4673901,2492,510
Property and equipment, net5970811111119193797264129128
Right-of-use asset200179171149127105821781841621,6312,509
Goodwill00———————09,72512,962
Total assets32,87130,73628,02126,26126,74527,77024,80025,56325,47315,86035,08536,870
Accounts payable1654645438277082306478041,0791,4921,0791,447
Accrued liabilities1,7811,7331,6401,7341,4971,5481,6301,5331,5631,6972,3251,982
Total current liabilities2,0352,4722,3503,3182,5862,0854,0894,6425,3253,90719,73813,452
Lease liability, non-current12197876236133941141017321,155
Total liabilities11,0049,5439,49711,94413,91916,01316,88419,01419,0249,20925,92819,732
Accumulated deficit(275,040)(275,709)(278,384)(282,604)(286,724)(292,352)(296,397)(301,506)(303,757)(309,535)(311,216)(314,511)
Total stockholders' equity21,86721,19318,52414,31712,82611,7577,9166,7896,7827,0549,56917,561
Total liabilities and equity32,87130,73628,02126,26126,74527,77024,80025,56325,47315,86035,08536,870
Common shares outstanding (cover page) thousands of shares7,0277,5737,5739898,0059,26911,01723,3281,6682,6922,69214,392
  • † Share count changed about 8x in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/14 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (VJET's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024†Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025†Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(1,927)(669)*(2,675)(4,220)(4,120)(5,628)*(4,045)(5,109)(2,251)(5,778)*(1,681)(3,295)
Stock-based compensation2*(5)*61317*18*9198*70*79*64266*
Depreciation and amortization—year only522526*530*531*531529*528*527*405382*
Net cash from operating activities(1,830)*(1,889)*(1,942)(1,697)*(2,768)*(2,864)*(2,338)(2,263)*(2,183)*(1,512)*(2,796)(2,861)*
Purchases of property and equipment1*18*2245*0*0*107*0*0*615*
Net cash from investing activities(1)*(18)*(22)(45)*0*0*(10)(13)*(28)*218*(1,319)(833)*
Proceeds from issuing common stock—year only——0*———2,174*———
Net cash from financing activities0*(107)*(110)267*4,020*4,469*(75)2,664*2,448*307*4,4683,896*
Net change in cash(1,831)*(2,014)*(2,074)(1,475)*1,252*1,605*(2,423)388*237*(987)*353202*
  • † Share count changed about 8x in the period ending 2024-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/14 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Catheter Precision6431,019(2,861)*14.4M0.6 quarters 10-QJun 30, 2026
Anteris Technologies Global249,9041,009(20,797)*97.5M12.0 quarters 10-QJun 30, 2026
STRATA Skin Sciences7,9129,292*(239)*5.9M33.1 quarters 10-KDec 31, 2025
Nuwellis3,9221,969(3,175)*3.6M1.2 quarters 10-QJun 30, 2026
Nu-Med Plus5.401.1*83.5M— 10-QJun 30, 2026
Glucotrack1,124not reported(3,616)*10.6M0.3 quarters 10-QJun 30, 2026
ENDRA Life Sciences1,740not reported(928)*1.5M1.9 quarters 10-QJun 30, 2026
Aethlon Medical4,934not reported(1,897)711,1362.6 quarters 10-QJun 30, 2026
Global Innovative Platforms24451(134)*49.8M1.8 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.